SNAKE BITE STUDY - PROTOCOL DEVELOPMENT WORKSHOP 11-12 March, 2013 Organized by Christian Medical College, Vellore Presentation by Dr. A. K. Mukherjee.

Slides:



Advertisements
Similar presentations
Research Techniques Made Simple: Enzyme Immunoassay and ELISA
Advertisements

Variability of Polyvalent ASV efficacy Clinical experience of Christian Medical College, Vellore & Government Vellore Medical College 1.
Snakes and Scorpions Dr J Rieck Department of Emergency Medicine Sheba Medical Centre.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
Advocacy for TB POC Diagnostic Javid Syed TB/HIV 15th Core Group Meeting Nov 3-4, Geneva.
Research Techniques Made Simple: The Use of Luminex Assays To Measure Cytokines Saami Khalifian, B.A., Giorgio Raimondi, Ph.D., & Gerald Brandacher, M.D.
Introduction to Genomics, Bioinformatics & Proteomics Brian Rybarczyk, PhD PMABS Department of Biology University of North Carolina Chapel Hill.
What Do Toxicologists Do?
Clinical Management Nutr 564: Management Summer 2003.
Laboratory Management - 1
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
ETIM-1 CSE 5810 CSE5810: Intro to Biomedical Informatics Mobile Computing to Impact Patient Health and Data Exchange and Statistical Analysis Presenter:
Joakim Dillner, M.D. Professor Department of Laboratory Medicine Karolinska Institutet Sweden Karolinska Institutet.
1 Course. 3 U nique options. Biomedical Science Discoveries, Diagnostics and Cures 1.
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Standard 5: Patient Identification and Procedure Matching Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
PERFORMANCE AUDIT REPORT ON MANAGEMENT OF PRIMARY HEALTH CARE (A CASE STUDY ON HEALTH CENTERS) 8/16/20151 Dr. Anna Nswilla CDHSMoHSW.
Issues in the Measurement of Oxytocin Armando J. Mendez Department of Medicine Division of Endocrinology, Diabetes And Metabolism Miller School of Medicine.
Benchmarking Energy Use in Commercial Buildings Satish Kumar, Ph.D. Lawrence Berkeley National Laboratory Public Sector Energy Management Workshop Mumbai,
BioLume BioLume Presentation January 10, BioLume BioLume Mission …..to develop and commercialize a broad library of proprietary bioluminescent proteins.
Allergen regulation in the future : what will be the place for recombinant allergens ? Jacqueline DAYAN-KENIGSBERG European Academy of Allergology and.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
©2009 RALPH SNYDERMAN 1 Personalized Health Care: The Foundation of Rational Health Reform Ralph Snyderman, MD Chancellor Emeritus, Duke University James.
Principles of ELISA. Immunoassay Immunochemical reactions form the basis of a diverse range of sensitive and specific clinical assays. In a typical immunochemical.
The Human Genome Project Jacob D. Schroeder Department of Chemistry and Chemical Engineering South Dakota School of Mines and Technology Rapid City, SD.
Marine Drug Development and Delivery Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM ,
Reporting of Adverse Drug Reactions: a study among Clinicians
SNAKEBITE PROTOCOL DEVELOPMENT WORKSHOP CMC, VELLORE
Understanding the Clinical Microbiology Laboratory Carol R. Quinter Ph.D. January, 2007.
Biomedical Research Objective 2 Biomedical Research Methods.
Collusion among Health Service Providers in India Need for Regulatory Enforcement PRESENTATION ON BACKGROUND AND DRAFT PROJECT METHODOLOGY.
Challenges of Non-Inferiority Trial Designs R. Sridhara, Ph.D.
A National survey of Snake bites in India (venomous and non-venomous): syndrome-snake species correlations, outcomes and ASV dose requirements Workshop.
LEVELS OF HEALTH CARE VINITA VANDANA.
LABORATORY MANAGEMENT The Administrative Process.
Objective the aim of this project was directly addressing a major health problem for Jordan by producing a guideline as a pilot in which the strengths.
STRATEGIES FOR THE DETECTION OF UNKNOWN BIOLOGICAL AGENTS Dr. Peter J. Stopa US Army Edgewood Chemical Biological Center Aberdeen Proving Ground, MD.
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
Laboratory of Methods Development and Quality Control Laboratory Overview September 22, 2005.
How To Design a Clinical Trial
Special Considerations for Archiving Data from Field Observations A Presentation for “International Workshop on Strategies for Preservation of and Open.
Perspective of different stakeholders in a research priority setting of a public health problem in LMIC Dr. Soumyadeep Bhaumik BioMedical Genomics Centre,
Assessing Learners The Teaching Center Department of Pediatrics UNC School of Medicine The Teaching Center.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran Asghari G. Faculty of Pharmacy and Pharmaceutical Sciences Isfahan University of.
California Department of Public Health / 1 CALIFORNIA DEPARTMENT OF PUBLIC HEALTH Standards and Guidelines for Healthcare Surge during Emergencies How.
1 Assessment of the Effectiveness of Small Pox Vaccines: Immunogenicity Assay Considerations Freyja Lynn Division of Bacterial, Parasitic and Allergenic.
IgM ELISA CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY Jan. 1998, p. 7–10 Vol. 5, No. 1 Copyright © 1998, American Society for Microbiology.
EBM --- Journal Reading Presenter :蕭皓天 Date : 2005/10/17.
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
1 Mobile Health Plus+ Presented by: Amaresh Sahoo (SIMSR, PGDM ) Prashant Gianani (SIMSR, PGDM )
The Status of the Nation’s Emergency Management System Gail L. Warden Chair, Committee on The Future of Emergency Care in the United States Health System.
Abstract Our research mainly applies Maximum Likelihood Method (MLE), Dynamic Programming, and Neighbor Joining Method in an attempt of shortening the.
How To Design a Clinical Trial
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Implementing the guideline
WHO Snake Antivenoms Website
Snakebites and antivenoms
AST SC’s Perspective on the Development and Use of ECVs
Towards epitope matching in kidney allocation
Principal recommendations
Department of Biotechnology University of Malakand
Research Techniques Made Simple: Enzyme Immunoassay and ELISA
General strategy for organelle-based proteomics: example of cardiac mitochondria.Top left, validation of organelle-specific proteins occurs at two independent.
GUIDELINES FOR THE COLLECTION OF PESTICIDE USAGE STATISTICS A summary
Dr. Donovan M, Mott N, Patel E, Gardner A
Component 11 Unit 7: Building Order Sets
EXTENT OF CHANGES IN PRE AND POSTDONATION DONOR VARIABLES IN SINGLE AND DOUBLE DOSE PLATELETPHERESIS AND ITS IMPLICATIONS ON DONOR SAFETY Dr. R. Sreedevi.
Unemployment Insurance Integrity Performance Measures
Presentation transcript:

SNAKE BITE STUDY - PROTOCOL DEVELOPMENT WORKSHOP 11-12 March, 2013 Organized by Christian Medical College, Vellore Presentation by Dr. A. K. Mukherjee Professor, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam Head and Coordinator, DBT Nodal Center for Medical Colleges and Biomedical Research Institutes of NE India, T.U. Affiliate Professor, School of Biological Sciences, University of Northern Colorado, Greeley, USA

Strategies to Improve Snakebite Treatment: Challenges and Progress

Efficient Management of Snakebite in India: Problems Encountered The following constrains as listed below are based on my 18 years of research experience on snake venom and snakebite management in India: No proper /methodical (computerized) record of snakebite data in most of the Govt. hospitals: lack of region specific true snakebite data. Geographical variation in snake venom composition and a detail study on region specific clinical manifestations following envenomation is lacking Lack of reliable venom detection kit : failure to understand which species of snake is bitten? Snakebite treatment protocol-which guideline is to be followed? Quality control (efficiency) and supply of antivenom: Who have been taking care? Monovalent Vs Polyvalent antivenom in snakebite therapy: Superiority of treatment Vs treatment cost needs to be worked out. Less attention has been paid for very poorly immunogenic, low molecular mass venom components which are difficult to neutralize by antivenom. Venom quality control for efficient antivenom production: should be addressed

Antivenom manufacturers All these problems have aroused because the lack of a proper coordination amongst…… Clinicians Toxinologists Antivenom manufacturers To address all these issues, “Toxinological Society of India” was established in 2011

Hospital based clinical work For Efficient Management of Snakebite, the Following Scheme is Proposed Snakebite Management Laboratory based venom and antivenom analysis Hospital based clinical work Improvement of treatment & quality of antivenom

Laboratory Based Snakebite Management Venomics Antivenomics Venom detection kit A proteomics approach to study geographical variation in venom composition & pathophysiology of venom components Proteomics based immunochemical analysis of antivenom ELISA based affordable venom detection kits Molecular basis of taxanomic identification of Indian snakes

Venomics: A proteomics Approach for Analysis of Snake Venom Components Analysis of complex mixture of snake venom demands an approach that effectively separates a complex mixture of proteins and peptides with varying size and charge. Traditional methods of venom analysis does not provide understanding of the complexity of venom toxicity as well as elucidating the major biochemical differences among snake families. Efficiency of the current proteomic techniques in identifying pharmaceutically important venom proteins and a better correlation of geographical variation in venom composition with clinical manifestation in snakebite patients has been proved Advantages characterized snake venom proteomes from different parts of India would provide information useful with regard to the potential clinical manifestation of these bites in a particular location This will also guiding antivenom choices for proper treatment of snakebite victims.

Differences in the venom composition between two species of Indian Cobra (Naja naja and Naja kaouthia) Impact on the severity of pathogenesis and antivenom treatment

Pictures of two specis of Indian Cobra Naja naja Naja kaouthia

Although the biochemical composition of Naja naja from different parts of India is well Characterized, but no information was available on the biochemicalcomposition and biological activity of N. kaouthia venom from India. Therefore, effort was given to characterize the biochemical properties of N. kaouthia venom from eastern India and to compare these properties with the N. naja venom of the same origin. Further, potency of a commercial polyvalent antivenom raised against N. naja in neutralizing the lethality and various pathophysiological effects of N. kaouthiaVenom was also explored.

A comparison of enzyme activity present in N. naja and N. kaouthia venom samples from eastern India

Source: Mukherjee, A. K. and Maity, C. R Source: Mukherjee, A.K. and Maity, C.R. (2002) Comparative Biochemistry and Physiology 131 (B), 125-132

Comparison of gel-filtration pattern of N. naja and N. kaouthia venom samples from eastern India

Naja Naja venom Naja Kaouthia venom

Properties Naja naja Naja kaouthia Table: A Comparison of Pathophysiology between N. naja and N. kaouthia Properties Naja naja Naja kaouthia Lethality (mg/body weight of mouse) 0.40 ± 0.08 0.7 ± 0.09 Hemorrhagic activity (20μg crude venom) Nil Myotoxicity (CPK release) (1U/l) 28.5 ± 3 19.2 ± 2.1 Edema ratio (15μg crude venom) 148.0 ± 3.1 140.0 ± 3.1 Minimum edema inducing dose (μg) 5.0 4.8 Indirect hemolytic activity (% of Hb release by 100 μg of protein) 86 ± 4.1 80 ± 3.8 Direct hemolytic activity (% of Hb release by 100 μg of protein) 50 ± 2.1 39 ± 2.5 Neurotoxicity Present Source: Mukherjee, A.K. and Maity, C.R. (2002) Comparative Biochemistry and Physiology 131 (B), 125-132

Neutralization of lethality and pathophysiology of N. naja and N. Kaouthia Venom samples by a commercial N. naja antivenom (mg venom / 100 mg antivenom) Neutralization potency

Antivenomics: Application of Proteomic Tools for Production of Efficient Antivenom for Proper Management of Snakebite Patients Proteomics-based immunochemical analysis (antivenomics) provides relevant information for outlining which venom mixtures cross-react with the most important components in medically-relevant venoms from a particular region. This type of approach may set the basis for the development of effective antivenoms on an immunologically sound basis which in turn will be beneficial for better treatment of snakebite patients

Venom Detection Kits Background Information: The diagnosis of snake envenomation is based on sensitive immunoassays Geographical and species specific variation in snake venom composition as well as high-immunological cross-reactivity impose a great challenge for development of ELISA-based venom detection kits. Recently, Wahby and Ibrahim (2008) and ibrahim et al. (2013) have demonstrated avidity based VDK (Avidity: an inexact measure of the binding strength of antibodies to multiple antigenic determinants on natural antigens)

Identification and Discrimination of Snake Venoms from Egyptian Cobras Source: Ibrahim et al. Toxicon 63 (2013) 88-97

Permission to collect snake venom from different geographical location IMPROVEMENT OF SNAKEBITE TREATMENT: SUMMARY OF SUGGESTIONS To identify PI’s from different fields but having a similar research interest. To identify coordinator(s) from each group, may be one from each region of India Snakebite data collection from different parts of country-permission from Govt. Permission to collect snake venom from different geographical location Approach to Govt. of India for allocation of more money in snakebite research Organization of workshop for project writing Organization of regular meetings amongst the interested PIs. Strengthening of Toxinological Society of India (TSI) and its activities